ARX Joins SAFE BioPharma Vendor Partner Program

ARX (Algorithmic Research), the leading provider of digital signature solutions (standard electronic signatures) to the life sciences and healthcare industries, today announced that it has become a vendor partner of SAFE-BioPharma Association, the non-profit that manages the SAFE-BioPharma™ digital identity and signature standard for the pharmaceutical and healthcare industries.

Recent changes in the criteria maintained by SAFE-BioPharma now permit SAFE-BioPharma member companies to deploy centralized server-based PKI digital signature solutions, such as ARX's CoSign digital signature solution. ARX's CoSign is the most widely used digital signature technology in the industry. With CoSign, SAFE-BioPharma user credentials can be accessed centrally from a network, or web portal, and utilized for signing from any location at any time.

"This advancement will enable companies to implement the strong user identity in the credentialing model put forth by SAFE-BioPharma, with the affordable, secure, and easy-to-use CoSign solution that eliminates client side tokens, smartcards, and software," explained Rodd Schlerf, Life Sciences and Healthcare Manager, ARX.

"We are pleased to welcome ARX to the SAFE-BioPharma Vendor Partner Program," said Mollie Shields-Uehling, CEO, SAFE-BioPharma Association.

About SAFE-BioPharma Association

SAFE-BioPharma Association is the non-profit association that created and manages the SAFE-BioPharma™ digital identity and signature standard for the pharmaceutical and healthcare industries. The SAFE-BioPharma industry standard is used to mitigate legal, regulatory and other business risk associated with business-to-business and business-to-regulator electronic transactions. It facilitates interoperability by providing a secure, enforceable, and regulatory-compliant way to verify identities of parties involved in electronic transactions. SAFE-BioPharma’s vision is to be a catalyst in transforming the biopharmaceutical and healthcare communities to a fully electronic business environment by 2012. The Association’s members include Amgen, AstraZeneca, Bristol-Myers Squibb, Genzyme, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, Procter & Gamble, Roche and Sanofi-Aventis. For more information, visit www.safe-biopharma.org.

CoSign makes it easy to digitally sign transactions, documents, and records by embedding the standard signature technology directly into mainstream business applications. CoSign produces a signature record for every signature it captures. This Portable Signature Format (CoSign PSF™) allows anyone to seamlessly verify and retain proof of identity, intent, and document integrity without costly, complicated, or proprietary software. CoSign keeps your business running smoothly by fully automating and quickly scaling processes at a low cost and with proper controls. Learn more at www.arx.com/products/cosign_moreinfo.php.

About ARX - The Digital Signature Company

ARX (Algorithmic Research) is a global provider of cost-efficient digital signature solutions for industries such as life sciences, healthcare, government, and engineering. ARX engineers and scientists have more than 20 years of experience in security and standard digital signature application. ARX helps businesses secure, streamline, and scale their business processes and transactions with the proper controls required by legislation, regulation, and industry best practice. Visit us at www.arx.com.

###

CoSign and SAPI are registered trademarks and CoSign PSF is a trademark of Algorithmic Research, Ltd. All other trade names and trademarks are the property of their respective holders.

Press Contact:
Edna Kaplan
KOGS Communication
781-639-1910/phone
kaplan@kogspr.com